Cargando…
Immunotherapeutic approaches to ovarian cancer treatment
Despite advances in combinatorial chemotherapy regimens and the advent of intraperitoneal chemotherapy administration, current therapeutic options for ovarian cancer patients are inadequate. Immunotherapy offers a novel and promising therapeutic strategy for treating ovarian tumors. Following the de...
Autores principales: | Chester, Cariad, Dorigo, Oliver, Berek, Jonathan S, Kohrt, Holbrook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372273/ https://www.ncbi.nlm.nih.gov/pubmed/25806106 http://dx.doi.org/10.1186/s40425-015-0051-7 |
Ejemplares similares
-
4-1BB agonism: adding the accelerator to cancer immunotherapy
por: Chester, Cariad, et al.
Publicado: (2016) -
Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment
por: Rajasekaran, Narendiran, et al.
Publicado: (2015) -
Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy
por: Chester, Cariad, et al.
Publicado: (2015) -
Development of Therapeutic Vaccines for Ovarian Cancer
por: Chow, Stephanie, et al.
Publicado: (2020) -
Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)